Ankylosing Spondylitis Market: Availability of Treatment Methods Makes Europe a Leading Regional Segment, Says TMR

The global ankylosing spondylitis market is anticipated to witness a lot of growth, due to immense efforts made by key players for improving research and development of products and services, according to a recent study by Transparency Market Research. The research study titled “Ankylosing Spondylitis Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025”, shares a large-scale outline of this market with its readers.

Based on molecule type, administrational route, and regional spread, the global ankylosing market is divided into several segments. Under molecule type, the biologics segment is anticipated to gain a leading position as a result of breakthrough research occurring in the field of clinical development. From a regional perspective, the global ankylosing market is classified into five segments: Asia Pacific, Europe, North America, Latin America, and the Middle East and Africa. On account of high occurrence of this condition along with availability of new treatment options, Europe has emerged as the winning regional segment based on market shares.

The global ankylosing spondylitis market is mainly growing as a result of considerable emphasis given on the treatment of this condition, especially to reduce the associated discomfort. The existence of numerous therapies using different drugs is a significant driving factor for the market. In future, the market is anticipated to expand as a result of extensive research and development undertaken by prominent players. Rise in patients needing treatment, provision of treatment to people from remote and underdeveloped regions, and availability of drug options are a few other factors that are beneficial for the global ankylosing spondylitis market’ growth.

Competition is substantially strong in the global ankylosing spondylitis market, as a result of numerous prominent companies operating in the industry. Pfizer Inc., Momenta Pharmaceuticals Inc., Celgene Corporation, Reliance Life Sciences Pvt. Ltd., Amgen Inc., and Regeneron Pharmaceuticals are some of the key players in the market.

Request a Brochure of the Report @

Leave a Reply